DnB Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,054
| Closed | -$209K | – | 1242 |
|
|
2025
Q4 | $209K | Sell |
2,054
-244,585
| -99% | -$19.6M | ﹤0.01% | 715 |
|
|
2025
Q3 | $13.5M | Buy |
246,639
+33,071
| +15% | +$1.65M | 0.05% | 241 |
|
|
2025
Q2 | $11.3M | Sell |
213,568
-32,191
| -13% | -$1.64M | 0.05% | 250 |
|
|
2025
Q1 | $10.6M | Buy |
245,759
+18,902
| +8% | +$957K | 0.05% | 252 |
|
|
2024
Q4 | $12.7M | Buy |
226,857
+43,006
| +23% | +$2.68M | 0.06% | 224 |
|
|
2024
Q3 | $12.5M | Sell |
183,851
-56,032
| -23% | -$3.16M | 0.06% | 221 |
|
|
2024
Q2 | $10.1M | Buy |
239,883
+76,847
| +47% | +$4.23M | 0.05% | 221 |
|
|
2024
Q1 | $11.3M | Buy |
163,036
+18,618
| +13% | +$1.18M | 0.06% | 216 |
|
|
2023
Q4 | $10.7M | Sell |
144,418
-2,763
| -2% | -$181K | 0.06% | 237 |
|
|
2023
Q3 | $10M | Buy |
147,181
+46,153
| +46% | +$3.92M | 0.06% | 223 |
|
|
2023
Q2 | $9.49M | Sell |
101,028
-19,059
| -16% | -$1.49M | 0.05% | 246 |
|
|
2023
Q1 | $8.14M | Sell |
120,087
-30,312
| -20% | -$1.95M | 0.05% | 261 |
|
|
2022
Q4 | $7.45M | Sell |
150,399
-100,683
| -40% | -$4.11M | 0.05% | 272 |
|
|
2022
Q3 | $8.16M | Buy |
251,082
+79,858
| +47% | +$3.29M | 0.06% | 243 |
|
|
2022
Q2 | $6.74M | Buy |
171,224
+9,896
| +6% | +$529K | 0.05% | 282 |
|
|
2022
Q1 | $11.3M | Buy |
161,328
+5,677
| +4% | +$415K | 0.07% | 218 |
|
|
2021
Q4 | $12.1M | Buy |
155,651
+23,318
| +18% | +$2.06M | 0.07% | 207 |
|
|
2021
Q3 | $12.6M | Buy |
132,333
+37,578
| +40% | +$3.97M | 0.08% | 197 |
|
|
2021
Q2 | $11.8M | Buy |
94,755
+62,294
| +192% | +$7.43M | 0.08% | 202 |
|
|
2021
Q1 | $4.28M | Buy |
32,461
+14,013
| +76% | +$1.92M | 0.03% | 361 |
|
|
2020
Q4 | $2.44M | Buy |
18,448
+1,613
| +10% | +$195K | 0.02% | 420 |
|
|
2020
Q3 | $1.72M | Buy |
16,835
+1,318
| +8% | +$114K | 0.02% | 425 |
|
|
2020
Q2 | $1.35M | Buy |
15,517
+1,585
| +11% | +$127K | 0.02% | 462 |
|
|
2020
Q1 | $808K | Sell |
13,932
-2,501
| -15% | -$203K | 0.01% | 513 |
|
|
2019
Q4 | $1.52M | Buy |
16,433
+3,025
| +23% | +$266K | 0.01% | 506 |
|
|
2019
Q3 | $1.21M | Buy |
13,408
+660
| +5% | +$75.2K | 0.01% | 519 |
|
|
2019
Q2 | $1.5M | Buy |
+12,748
| New | +$1.28M | 0.02% | 469 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
DnB Asset Management's EXAS Position: Q1 2026 in Review
DnB Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,054 shares — an estimated $209K sold.
DnB Asset Management first reported a position in EXAS in Q2 2019 and held it in 27 quarters. The position peaked at $13.5M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- DnB Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- DnB Asset Management sold 2,054 Exact Sciences shares in Q1 2026, an estimated $209K.
- DnB Asset Management first reported a position in Exact Sciences in Q2 2019 and held it in 27 quarters.
- DnB Asset Management's Exact Sciences position peaked at $13.5M in Q3 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.